![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1537704
µ¿°ø°è : ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Ç⡤Åë°è, ¼ºÀå ¿¹Ãø(2024-2029³â)Pupillometer - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) |
µ¿°ø°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 4¾ï 2,243¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2029³â¿¡´Â 6¾ï 259¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£(2024-2029³â) CAGRÀº 7.40%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
ÀÌ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¼öµ¿ µ¿°ø °Ë»çº¸´Ù µ¿°ø°è¿Í °ü·ÃµÈ ÀÎ½Ä Áõ°¡, ±â¼ú ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÏ´Â ´Ù¸¥ ¿äÀÎÀ¸·Î´Â µ¿°ø°è¸¦ »ç¿ëÇØ¾ß ÇÏ´Â ¸¸¼ºÁúȯÀÇ À¯º´·üÀÌ ±ÞÁõÇÏ´Â °ÍÀ» µé ¼ö ÀÖ½À´Ï´Ù.
¿ì¿ïÁõ, ºÒ¾ÈÀå¾Ö, ÆÄŲ½¼º´, ÀÚÆó ½ºÆåÆ®·³ Àå¾Ö¸¦ ¾Î°í ÀÖ´Â »ç¶÷µéÀº Àڱؿ¡ ´ëÇÑ µ¿°ø ÃøÁ¤ ¹ÝÀÀ¿¡ ÀÌ»óÀÌ ÀÖ½À´Ï´Ù. µ¿°ø °Ë»ç´Â °³ÀÎÀÇ Á¤»óÀûÀÎ ¾È±¸ ¿îµ¿°ú Áúº´À¸·Î ÀÎÇØ ¹æÇع޴ ³ú Ȱµ¿À» ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. µû¶ó¼ ½Å°æ ÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °ËÁøÀ²°ú µ¿°ø°è ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î World Alzheimer's Report 2023¿¡ µû¸£¸é 2023³â 65¼¼ ÀÌ»ó ¹Ì±¹ÀÎ 670¸¸ ¸íÀÌ ¾ËÃ÷ÇÏÀ̸Ӻ´¿¡ °É¸± °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, 73%°¡ 75¼¼ ÀÌ»óÀÔ´Ï´Ù. ÀÌ Áúº´Àº ¾È±¸¿¡ ºñÁ¤»óÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. µ¿°ø°è ¼ö¿ä´Â ¿¹Ãø ±â°£ Áß Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
±¸½É¼º µ¿°ø °á¼Õ(APD)Àº ½Ã½Å°æ, ³úÁ¾¾ç, ¸Á¸· ¶Ç´Â ³úÇ÷°ü Áúȯ, ¾à½Ã¿¡¼ ¹ß»ýÇÒ ¼ö ÀÖ´Â ºñ´ëμºÀÇ ÁöÇ¥ÀÔ´Ï´Ù. ƯÈ÷ Áúº´À̳ª Àå¾Ö°¡ ÁÂ¿ì ºñ´ëĪÀ¸·Î ³ªÅ¸³ª´Â °æ¿ì¿¡ ¹ß»ýÇÕ´Ï´Ù. µû¶ó¼ ³úÁ¾¾ç°ú °°Àº Áúº´ÀÇ À¯º´·üÀÌ ±ÞÁõÇÔ¿¡ µû¶ó ³úÁ¾¾ç ȯÀÚÀÇ APD¸¦ °¨ÁöÇÏ´Â µ¥ »ç¿ëµÇ´Â µ¿°ø°è ¼ö¿ä Áõ°¡·Î À̾îÁý´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ÀÓ»óÁ¾¾çÇÐȸ(ASCO)ÀÇ Ã߻꿡 µû¸£¸é 2022³â ¹Ì±¹¿¡¼ ³ú¿Í ô¼ö ¿ø¹ß¼º ¾Ï Á¾¾çÀ¸·Î Áø´Ü¹ÞÀº ¼ºÀÎÀº 25,050¸íÀ¸·Î Ãß»êµË´Ï´Ù.
¼ö³â µ¿¾È ¼öµ¿ µ¿°ø Æò°¡´Â ȯÀÚ¿¡ ´ëÇÑ µ¿°ø Á¤º¸¸¦ ¾ò±â À§ÇÑ ÁÖ¿ä ¹æ¹ýÀ¸·Î »ç¿ëµÇ¾î ¿Ô½À´Ï´Ù. °³¹ßµµ»ó±¹ ¹× Àú°³¹ß ±¹°¡¿¡¼ µ¿°ø°è äÅÃÀ» ´Ã¸®±â À§ÇØ ¹Î°£ ¹× °ø°ø ±â°üÀÌ ´Ù¾çÇÑ ±¸»óÀ» ÃëÇÏ´Â °ÍÀº ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 2¿ù SBI Àç´ÜÀº Àεµ ÃÖÃÊÀÇ µ§¸¶Å©»ê µ¿°ø°è¿Í °°Àº Èñ±Í Àåºñ¸¦ Æ÷ÇÔÇÑ ½Ã¼³À» ¾÷±×·¹À̵åÇϱâ À§ÇØ ÀÚ¼± ÀÇ·á ±â°ü¿¡ 1.41 ·çÇÇ(16¸¸ ´Þ·¯)¸¦ ±âºÎÇß½À´Ï´Ù. ÀÇ»ç¼ÒÅë, ¾ð¾î, û°¢ Àå¾Ö°¡ ÀÖ´Â »ç¶÷µé¿¡°Ô Àû½Ã¿¡ Áø´Ü, ÷´Ü ÀÇ·á Àåºñ, °³º°ÈµÈ ÈÄ¼Ó Ä¡·á´Â »îÀÇ ÁúÀ» Å©°Ô Çâ»ó½Ã۰í Àå¾ÖÀÇ ¿µÇâÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ¿¬±¸¼Ò´Â µ¿°ø°è, ½ºÆ®·Îº¸½ºÄÚÇÁ µî Àεµ¿¡¼ ÈçÈ÷ º¼ ¼ö ¾ø´Â ¸Å¿ì Èñ±ÍÇÑ ÀåºñµéÀ» °ø°³Çß½À´Ï´Ù.
µû¶ó¼ ¾Õ¼ ¾ð±ÞÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß ½ÃÀåÀÌ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª µ¿°ø°èÀÇ ³ôÀº °¡°Ý°ú Àü¹® ÀÓ»óÀÇ ºÎÁ·Àº ½ÅÈï ±¹°¡¿¡¼ µ¿°ø°è º¸±Þ¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ´Â µ¿°ø°è ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.
µ¿°ø°è ½ÃÀåÀº Áö¿ªÀû»Ó¸¸ ¾Æ´Ï¶ó Àü ¼¼°è¿¡¼ »ç¾÷À» ¿î¿µÇÏ´Â ±â¾÷ÀÌ ´Ù¼ö Á¸ÀçÇϹǷΠ°æÀïÀÌ Ä¡¿ÇÕ´Ï´Ù. ½ÃÀå ÁøÃâ±â¾÷Àº µ¿°ø°è ½ÃÀå¿¡¼ °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ Á¦Ç° Ãâ½Ã, ÀμöÇÕº´(M&A), Á¦ÈÞ µî ´Ù¾çÇÑ Àü·«À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå¿¡ Âü¿©Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷Àº NeurOptics Inc., Essilor Group(Essilor Instruments), Visionix, ¹Ì±¹ Ophthalmic, NIDEK SA, HAAG-STREIT GROUP, Reichert Inc., Konan Medical USA Inc., Good-Lite Company, Grobet USA(Vigor Optical)ÀÔ´Ï´Ù.
The Pupillometer Market size is estimated at USD 422.43 million in 2024, and is expected to reach USD 602.59 million by 2029, growing at a CAGR of 7.40% during the forecast period (2024-2029).
The major factor leading to the growth of the market studied includes the rise in awareness associated with pupillometers over manual pupillary examination, coupled with technological advancements. Other factors that contribute to the growth of the market include the surge in the prevalence of chronic disorders requiring the use of a pupillometer.
People suffering from depression, anxiety, Parkinson's disease, and autism spectrum disorder had abnormal pupillometry responses to stimuli. Pupillometry aids in understanding an individual's normal eye performance and brain activity disrupted by sickness. Hence, the growing burden of neurological diseases is expected to increase the screening rate and demand for pupilometers, thereby boosting market growth. For instance, according to the World Alzheimer's Report 2023, an estimated 6.7 million Americans aged 65 and older had Alzheimer's in 2023. Seventy-three percent were aged 75 years or older. This disease led to an abnormal effect on the eye. The demand for pupillometers is likely to increase during the forecast period.
Afferent pupillary defect (APD) is a measure of asymmetry that may occur with the optic nerve, brain tumors, retinal or cerebral vascular disease, and amblyopia. It occurs specifically when the disease or disorder presents asymmetrically. Hence, a surge in the prevalence of diseases such as brain tumors leads to a rise in demand for pupillometers, which are used to detect APD in patients suffering from brain tumors. For instance, according to an estimate by the American Society of Clinical Oncology (ASCO), 25,050 adults were estimated to be diagnosed with primary cancerous tumors of the brain and spinal cord in the United States in 2022.
Over the years, manual pupil assessment has remained a major way of obtaining pupillary information about a patient. The various initiatives taken by private and public organizations to increase the adoption of pupillometer in developing and underdeveloped countries are expected to boost market growth during the forecast period. For instance, in February 2023, the SBI Foundation donated INR 1.41 crore (USD 0.16 million) to a charitable medical institute to upgrade its facilities, including rare equipment such as India's first Danish pupillometer. The timely diagnosis, advanced medical equipment, and personalized follow-up care available to people with communication, speech, and hearing impairments can significantly improve their quality of life and reduce the impact of their disabilities. The institute unveiled several highly unusual pieces of equipment, including the pupilometer and stroboscope, which are not typically found in India.
Therefore, owing to the aforementioned factors, the market studied is anticipated to witness growth during the forecast period. However, the high cost of pupillometers and the lack of specialized clinicians impact their penetration in emerging countries. This, in turn, affects the growth of the pupillometer market.
The pupillometer market is competitive due to the presence of several companies operating globally as well as regionally. The market players are adopting various strategies such as product launches, mergers and acquisitions, and collaboration to stay competitive in the pupillometer market. The key companies operating in the market are NeurOptics Inc., Essilor Group (Essilor Instruments), Visionix, US Ophthalmic, NIDEK SA, HAAG-STREIT GROUP, Reichert Inc., Konan Medical USA Inc., Good-Lite Company, and Grobet USA (Vigor Optical).